Immunogenicity of SARS-CoV-2 vaccination in rituximab-treated patients: Effect of timing and immunologic parameters
Daniel Magliulo, Stefanie D. Wade, Vasileios C. Kyttaris
Topics & Concepts
VaccinationMedicineImmunologyImmunogenicityHypogammaglobulinemiaImmune systemRituximabAntibodyConcomitantTiterInternal medicineSARS-CoV-2 and COVID-19 ResearchPeripheral Neuropathies and DisordersHeparin-Induced Thrombocytopenia and Thrombosis